By JNi.Media
This collapse comes in the wake of the world's biggest generic drugs maker attempt to dominate its market with a $40.5 billion acquisition of Allergan's generics business last year. It was a bad call.
Teva Pharmaceutical is moving its global headquarters from Petach Tikva to Ra'anana, sources told the Globes business newspaper. The giant generic drugs company reputedly will pay $125 million for the land and new buildings on a site owned by Toyota's Israeli importer. Some of the land at Teva's current headquarters will be sold, and the […]